Hagens Berman has earned an enviable reputation as experts in this often-confusing, combative area of corporate litigation in which we have recovered billions of dollars in settlements. Our antitrust and competition legal team takes an innovative, efficient approach to antitrust law and tries each case with unmatched determination.
Hagens Berman’s antitrust and competition attorneys work to preserve healthy competition and fair trade in the marketplace by protecting consumers and businesses that purchase goods and services from price-fixing, market allocation agreements, monopolistic schemes and other violations of antitrust law.
Our attorneys have a deep understanding of the legal and economic issues within the marketplace, allowing us to employ groundbreaking market theories that shed light on monopolistic, restrictive and anti-competitive practices in violation of U.K., federal and state antitrust and unfair competition laws.
Hagens Berman currently represents millions of consumers in several high-profile class-action antitrust lawsuits, and takes on major antitrust litigation that has the potential to improve market conditions for consumers and businesses. We have represented plaintiffs in markets as diverse as debit and credit cards services, personal computer components, television screens, electric and gas power, airlines, personal computer software, computer games and internet services.
The firm’s antitrust efforts have truly been historic. Hagens Berman served as co-lead counsel in what is the largest approved antitrust class-action settlement in history against Visa and MasterCard, at $14.7 billion. The firm also led price-fixing charges against Apple and five of the nation’s largest publishing companies regarding e-books. The case went all the way to the Supreme Court, culminating when Hagens Berman reached a final settlement with all defendants (including Apple). Consumers received more than $560 million – an outstanding outcome of more than twice the amount of losses suffered.
In the pharmaceutical arena, Hagens Berman represents purchasers of all types in lawsuits alleging that drug companies illegally blocked or delayed generic drugs from coming to market. By keeping generics out of the market, drug companies force purchasers to continue buying their expensive brand-name drugs, lining drug companies' pockets at the expense of those who pay for drugs. Our firm's pharmaceutical antitrust recoveries have returned many hundreds of millions of dollars to purchasers.
We are proud of our track record which includes some of the largest recoveries in the nation. As in all practice areas we fight until we have achieved a high percent recovery for our clients.